Sun Pharma Corporate Overview
Western Europe & Other Markets at a glance
Market Presence
Amongst the leading Indian Companies
.
Product Portfolio
Focus
Sales Force
Local Manufacturing
SUN
PHARMA
• Across all major markets in Western Europe, Canada, A&NZ, Japan
and few other markets
Expanding basket of products including specialty brands,
injectable & hospital products as well as products for retail market
• Development and commercialization of complex generics and
differentiated products to drive sustainable and profitable growth
•
Distribution led model
• Sales force for Specialty products
•
At Canada, Japan, Australia, Israel and Hungary + Servicing from
India facilities
• Acquired 14 established prescription brands from Novartis in
March'16.
Japan Presence
•
Acquired Pola Pharma in Japan in Jan'19
•
Launched Ilumya in Japan in September 2020
© Sun Pharmaceutical Industries Limited. All Rights Reserved.
30View entire presentation